(Q31055338)

28 June 2017

title

Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells (English)

1 reference

28 June 2017

Ingrid Hilger

1

1 reference

28 June 2017

Yvonne Leistner

2

1 reference

28 June 2017

Alexander Berndt

3

1 reference

28 June 2017

Christine Fritsche

4

1 reference

28 June 2017

Karl Michael Haas

5

1 reference

28 June 2017

Hartwig Kosmehl

6

1 reference

28 June 2017

Werner A Kaiser

7

1 reference

28 June 2017

language of work or name

English

0 references

publication date

30 April 2004

1 reference

28 June 2017

1 reference

28 June 2017

volume

14

1 reference

28 June 2017

issue

6

1 reference

28 June 2017

page(s)

1124-1129

1 reference

Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group

28 June 2017

cites work

1 reference

12 December 2020

Shedding light onto live molecular targets

1 reference

12 December 2020

The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review

1 reference

12 December 2020

Oral squamous cell carcinoma invasion is associated with a laminin-5 matrix re-organization but independent of basement membrane and hemidesmosome formation. clues from an in vitro invasion model.

1 reference

12 December 2020

Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2.

1 reference

12 December 2020

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Fluorescence molecular tomography resolves protease activity in vivo

1 reference

12 December 2020

Three-dimensional time-resolved optical tomography of a conical breast phantom.

1 reference

12 December 2020

Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256)

1 reference

12 December 2020

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs

1 reference

12 December 2020

The value of fluorescence techniques in gastrointestinal endoscopy: better than the endoscopist's eye? I: The European experience

1 reference

12 December 2020

Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies

1 reference

12 December 2020

[Basaloid squamous epithelial carcinoma (basaloid-squamous carcinoma) of the mouth floor. Differential diagnosis and response to neoadjuvant chemotherapy]

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

In vivo imaging of tumors with protease-activated near-infrared fluorescent probes

1 reference

12 December 2020

Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands

1 reference

12 December 2020

Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo

1 reference

12 December 2020

High-resolution chromoendoscopy for the diagnosis of diminutive colon polyps: implications for colon cancer screening

1 reference

12 December 2020

Herceptin in the adjuvant setting: phase III trials begin

1 reference

12 December 2020

Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging

1 reference

12 December 2020

10.1007/S00330-004-2257-9

Identifiers

DOI

1 reference

Dimensions Publication ID

28 June 2017

1024601209

0 references

1 reference